Harpagoside
Names | |
---|---|
IUPAC name
(1S,4aS,5R,7S,7aS)-1-(β-D-Glucopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl (2E)-3-phenylacrylate | |
Identifiers | |
19210-12-9 | |
ChemSpider | 4444874 |
Jmol interactive 3D | Image |
PubChem | 5281542 |
UNII | 8KGS1DC5ZU |
| |
| |
Properties | |
C24H30O11 | |
Molar mass | 494.49 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Harpagoside is a chemical compound classified as an iridoid glycoside.[1] It is an chemical constituent of the plant Harpagophytum procumbens (devil’s claw).[2]
In vitro, it inhibits NF-κB activation (a protein complex that controls transcription of DNA), suppresses lipopolysaccharide-induced iNOS, and inhibits COX-2 expression.[2]
References
- ↑ Milen I. Georgiev, Nina Ivanovska, Kalina Alipieva, Petya Dimitrov, Robert Verpoorte (2013). "Harpagoside: from Kalahari Desert to pharmacy shelf". Phytochemistry 92: 8–15. doi:10.1016/j.phytochem.2013.04.009.
- 1 2 Tom Hsun-Wei Huang, Van H Tran, Rujee K Duke, Sharon Tan, Sigrun Chrubasik, b, Basil D Roufogalis, Colin C Duke (2006). "Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-κB activation". Journal of Ethnopharmacology 104 (1–2): 149–155. doi:10.1016/j.jep.2005.08.055.
This article is issued from Wikipedia - version of the Thursday, February 25, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.